Vernalis has obtained a final payment of $2.5m from its drug discovery collaboration with Genentech, a member of the Roche Group. The collaboration was formed to discover novel small molecules for an undisclosed target using Vernalis' ...
Tags: Vernalis, drug discovery, drug
Vernalis has reached a research milestone as part of the oncology drug discovery alliance with French pharmaceutical company, Servier. Under the drug discovery program, Vernalis will receive a payment of €0.5m from Servier on ...
Tags: drug discovery platforms, oncology drug discovery, undisclosed oncology